Skip to main content
. 2022 Nov 3;7(45):40659–40681. doi: 10.1021/acsomega.2c05307

Figure 3.

Figure 3

Bioactivation of BTZ043 by DprE1 and cofactor FADH2, and subsequent nucleophilic addition by Cys387.